10 20 30 40 50 60 70 80 4J12 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER IMMUNE SYSTEM 31-JAN-13 4J12
TITLE MONOMERIC FC
COMPND MOL_ID: 1; COMPND 2 MOLECULE: HUMAN FC FRAGMENT; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 137-345; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: HEK293
KEYWDS IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
EXPDTA X-RAY DIFFRACTION
AUTHOR T.ISHINO,M.WANG,L.MOSYAK,A.TAM,W.DUAN,K.SVENSON, JOYCE,A,D.O'HARA, AUTHOR 2 L.LIN,W.SOMERS,R.KRIZ
REVDAT 2 24-JUL-13 4J12 1 JRNL REVDAT 1 01-MAY-13 4J12 0
JRNL AUTH T.ISHINO,M.WANG,L.MOSYAK,A.TAM,W.DUAN,K.SVENSON,A.JOYCE, JRNL AUTH 2 D.M.O'HARA,L.LIN,W.S.SOMERS,R.KRIZ JRNL TITL ENGINEERING A MONOMERIC FC DOMAIN MODALITY BY JRNL TITL 2 N-GLYCOSYLATION FOR THE HALF-LIFE EXTENSION OF JRNL TITL 3 BIOTHERAPEUTICS. JRNL REF J.BIOL.CHEM. V. 288 16529 2013 JRNL REFN ISSN 0021-9258 JRNL PMID 23615911 JRNL DOI 10.1074/JBC.M113.457689
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 TITL DEVELOPMENT OF A NOVEL MONOMERIC FC MODALITY FOR THE REMARK 1 TITL 2 HALF-LIFE EXTENSION OF BIOTHERAPEUTICS REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN
REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.1 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.11 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 3 NUMBER OF REFLECTIONS : 26861 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.223 REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.910 REMARK 3 FREE R VALUE TEST SET COUNT : 1319 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 13 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.98 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.89 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2389 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2513 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2276 REMARK 3 BIN R VALUE (WORKING SET) : 0.2519 REMARK 3 BIN FREE R VALUE : 0.2389 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.73 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 113 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1665 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 103 REMARK 3 SOLVENT ATOMS : 159 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.82 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.35 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.50780 REMARK 3 B22 (A**2) : -0.50780 REMARK 3 B33 (A**2) : 1.01550 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.31 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.14 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.943 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1834 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2515 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 599 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 51 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 253 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1834 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 256 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2059 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.15 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.18 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.20 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 4J12 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-FEB-13. REMARK 100 THE RCSB ID CODE IS RCSB077461.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 270 REMARK 200 PH : 5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26861 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE-WAVELENGHT REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASES REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.55 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.2 MAMMONIUM SULFATE AND 200 MM REMARK 280 SODIUM FLUORIDE , PH 5, EVAPORATION, TEMPERATURE 300K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 1 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -Y,-X,-Z+2/3 REMARK 290 5555 -X+Y,Y,-Z+1/3 REMARK 290 6555 X,X-Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.97900 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 97.95800 REMARK 290 SMTRY1 4 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 97.95800 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 48.97900 REMARK 290 SMTRY1 6 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7200 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22780 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 54.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 235
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NH2 ARG A 292 OD1 ASN A 421 6455 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 360 -176.20 -69.84 REMARK 500 HIS A 435 18.80 58.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 LYS A 340 23.6 L L OUTSIDE RANGE REMARK 500 MET A 358 24.3 L L OUTSIDE RANGE REMARK 500 LYS A 360 24.3 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 716 DISTANCE = 5.13 ANGSTROMS REMARK 525 HOH A 729 DISTANCE = 6.91 ANGSTROMS REMARK 525 HOH A 748 DISTANCE = 11.93 ANGSTROMS
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BMA A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MAN A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MAN A 506 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A 507 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A 508
DBREF 4J12 A 236 444 UNP Q6PYX1 Q6PYX1_HUMAN 137 345
SEQADV 4J12 ASN A 235 UNP Q6PYX1 EXPRESSION TAG SEQADV 4J12 ASN A 364 UNP Q6PYX1 SER 265 ENGINEERED MUTATION SEQADV 4J12 ASN A 407 UNP Q6PYX1 TYR 308 ENGINEERED MUTATION SEQADV 4J12 THR A 409 UNP Q6PYX1 LYS 310 ENGINEERED MUTATION
SEQRES 1 A 210 ASN GLY GLY PRO SER VAL PHE LEU PHE PRO PRO LYS PRO SEQRES 2 A 210 LYS ASP THR LEU MET ILE SER ARG THR PRO GLU VAL THR SEQRES 3 A 210 CYS VAL VAL VAL ASP VAL SER HIS GLU ASP PRO GLU VAL SEQRES 4 A 210 LYS PHE ASN TRP TYR VAL ASP GLY VAL GLU VAL HIS ASN SEQRES 5 A 210 ALA LYS THR LYS PRO ARG GLU GLU GLN TYR ASN SER THR SEQRES 6 A 210 TYR ARG VAL VAL SER VAL LEU THR VAL LEU HIS GLN ASP SEQRES 7 A 210 TRP LEU ASN GLY LYS GLU TYR LYS CYS LYS VAL SER ASN SEQRES 8 A 210 LYS ALA LEU PRO ALA PRO ILE GLU LYS THR ILE SER LYS SEQRES 9 A 210 ALA LYS GLY GLN PRO ARG GLU PRO GLN VAL TYR THR LEU SEQRES 10 A 210 PRO PRO SER ARG GLU GLU MET THR LYS ASN GLN VAL ASN SEQRES 11 A 210 LEU THR CYS LEU VAL LYS GLY PHE TYR PRO SER ASP ILE SEQRES 12 A 210 ALA VAL GLU TRP GLU SER ASN GLY GLN PRO GLU ASN ASN SEQRES 13 A 210 TYR LYS THR THR PRO PRO VAL LEU ASP SER ASP GLY SER SEQRES 14 A 210 PHE PHE LEU ASN SER THR LEU THR VAL ASP LYS SER ARG SEQRES 15 A 210 TRP GLN GLN GLY ASN VAL PHE SER CYS SER VAL MET HIS SEQRES 16 A 210 GLU ALA LEU HIS ASN HIS TYR THR GLN LYS SER LEU SER SEQRES 17 A 210 LEU SER
MODRES 4J12 ASN A 364 ASN GLYCOSYLATION SITE MODRES 4J12 ASN A 297 ASN GLYCOSYLATION SITE
HET NAG A 501 14 HET NAG A 502 14 HET BMA A 503 11 HET MAN A 504 11 HET NAG A 505 14 HET MAN A 506 11 HET NAG A 507 14 HET NAG A 508 14
HETNAM NAG N-ACETYL-D-GLUCOSAMINE HETNAM BMA BETA-D-MANNOSE HETNAM MAN ALPHA-D-MANNOSE
FORMUL 2 NAG 5(C8 H15 N O6) FORMUL 2 BMA C6 H12 O6 FORMUL 2 MAN 2(C6 H12 O6) FORMUL 4 HOH *159(H2 O)
HELIX 1 1 LYS A 246 MET A 252 1 7 HELIX 2 2 LEU A 309 ASN A 315 1 7 HELIX 3 3 SER A 354 THR A 359 1 6 HELIX 4 4 LYS A 414 GLN A 419 1 6 HELIX 5 5 LEU A 432 ASN A 434 5 3
SHEET 1 A 4 SER A 239 PHE A 243 0 SHEET 2 A 4 GLU A 258 VAL A 266 -1 O VAL A 262 N PHE A 241 SHEET 3 A 4 TYR A 300 THR A 307 -1 O LEU A 306 N VAL A 259 SHEET 4 A 4 LYS A 288 THR A 289 -1 N LYS A 288 O VAL A 305 SHEET 1 B 4 SER A 239 PHE A 243 0 SHEET 2 B 4 GLU A 258 VAL A 266 -1 O VAL A 262 N PHE A 241 SHEET 3 B 4 TYR A 300 THR A 307 -1 O LEU A 306 N VAL A 259 SHEET 4 B 4 GLU A 293 GLU A 294 -1 N GLU A 293 O ARG A 301 SHEET 1 C 4 VAL A 282 VAL A 284 0 SHEET 2 C 4 LYS A 274 VAL A 279 -1 N VAL A 279 O VAL A 282 SHEET 3 C 4 TYR A 319 SER A 324 -1 O LYS A 322 N ASN A 276 SHEET 4 C 4 ILE A 332 ILE A 336 -1 O ILE A 332 N VAL A 323 SHEET 1 D 4 GLN A 347 LEU A 351 0 SHEET 2 D 4 GLN A 362 PHE A 372 -1 O LEU A 368 N TYR A 349 SHEET 3 D 4 PHE A 404 ASP A 413 -1 O VAL A 412 N VAL A 363 SHEET 4 D 4 TYR A 391 THR A 393 -1 N LYS A 392 O THR A 409 SHEET 1 E 4 GLN A 347 LEU A 351 0 SHEET 2 E 4 GLN A 362 PHE A 372 -1 O LEU A 368 N TYR A 349 SHEET 3 E 4 PHE A 404 ASP A 413 -1 O VAL A 412 N VAL A 363 SHEET 4 E 4 VAL A 397 LEU A 398 -1 N VAL A 397 O PHE A 405 SHEET 1 F 4 GLN A 386 GLU A 388 0 SHEET 2 F 4 ALA A 378 SER A 383 -1 N SER A 383 O GLN A 386 SHEET 3 F 4 PHE A 423 MET A 428 -1 O SER A 424 N GLU A 382 SHEET 4 F 4 TYR A 436 LEU A 441 -1 O LYS A 439 N CYS A 425
SSBOND 1 CYS A 261 CYS A 321 1555 1555 2.03 SSBOND 2 CYS A 367 CYS A 425 1555 1555 2.03
LINK O4 NAG A 501 C1 NAG A 502 1555 1555 1.40 LINK O6 BMA A 503 C1 MAN A 506 1555 1555 1.40 LINK O4 NAG A 502 C1 BMA A 503 1555 1555 1.40 LINK ND2 ASN A 364 C1 NAG A 508 1555 1555 1.40 LINK O2 MAN A 506 C1 NAG A 507 1555 1555 1.41 LINK O3 BMA A 503 C1 MAN A 504 1555 1555 1.42 LINK O2 MAN A 504 C1 NAG A 505 1555 1555 1.42 LINK ND2 ASN A 297 C1 NAG A 501 1555 1555 1.43
CISPEP 1 GLY A 236 GLY A 237 0 1.05 CISPEP 2 TYR A 373 PRO A 374 0 -3.29
SITE 1 AC1 5 VAL A 264 ASP A 265 GLN A 295 ASN A 297 SITE 2 AC1 5 NAG A 502 SITE 1 AC2 7 VAL A 264 ARG A 301 NAG A 501 BMA A 503 SITE 2 AC2 7 MAN A 506 HOH A 683 HOH A 755 SITE 1 AC3 5 PHE A 243 NAG A 502 MAN A 504 MAN A 506 SITE 2 AC3 5 HOH A 715 SITE 1 AC4 3 PHE A 241 BMA A 503 NAG A 505 SITE 1 AC5 1 MAN A 504 SITE 1 AC6 5 PHE A 243 NAG A 502 BMA A 503 NAG A 507 SITE 2 AC6 5 HOH A 755 SITE 1 AC7 6 PHE A 243 LYS A 246 THR A 260 ARG A 301 SITE 2 AC7 6 MAN A 506 HOH A 642 SITE 1 AC8 3 GLN A 362 ASN A 364 THR A 411
CRYST1 64.224 64.224 146.937 90.00 90.00 120.00 P 31 1 2 6
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.015571 0.008990 0.000000 0.00000
SCALE2 0.000000 0.017979 0.000000 0.00000
SCALE3 0.000000 0.000000 0.006806 0.00000